← Evidence map

ReviewUnited European gastroenterology journal2014

Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?

Tim RainePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25360311